GlassScriptPhysician profile
Girish P Joshi
NPI 1730141516
$238,672.17
in general payments reported to CMS, 2019-2025
13 companies · $150 in 2025
The $150 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186K · 2020: $15K · 2021: $24K · 2022: $5,359 · 2023: $7,235 · 2024: $700 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,423 · Travel and Lodging: $1,225 · Food and Beverage: $417 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,422.50 |
| Travel and Lodging | $1,225.20 |
| Food and Beverage | $417.21 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $198,812.70 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $20,911.80 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $7,768.32 | 2019-2023 | Bridion |
| Pfizer INC. | $3,780.00 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $3,616.50 | 2019-2025 | |
| Acadia Pharmaceuticals INC | $3,087.50 | 2021-2022 | |
| Grifols USA, LLC | $117.30 | 2019 | |
| Csl Behring | $117.03 | 2019 | |
| Covidien LP | $112.00 | 2019 | |
| Baudax Bio INC. | $103.26 | 2021 | |
| Myoscience INC. | $84.89 | 2019 | |
| Heron Therapeutics, INC. | $83.62 | 2025 | Aponvie |
| Acacia Pharma INC | $77.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Girish Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.